@article{Dominik Selleslag_Stefan Suciu_Giovanna Meloni_Petra Muus_Constantijn J.M. Halkes_Adriano Venditti_Safaa M. Ramadan_Hans Pruijt_Liv Meert_Marco Vignetti_Jean-Pierre Marie_Sébastian Wittnebel_Theo de Witte_Sergio Amadori_Roelof Willemze_Frédéric Baron_2017, place={Pavia, Italy}, title={Low-dose clofarabine in combination with a standard remission induction in patients aged 18–60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial}, volume={102}, url={https://haematologica.org/article/view/7985}, DOI={10.3324/haematol.2016.153130}, number={2}, journal={Haematologica}, author={Dominik Selleslag and Stefan Suciu and Giovanna Meloni and Petra Muus and Constantijn J.M. Halkes and Adriano Venditti and Safaa M. Ramadan and Hans Pruijt and Liv Meert and Marco Vignetti and Jean-Pierre Marie and Sébastian Wittnebel and Theo de Witte and Sergio Amadori and Roelof Willemze and Frédéric Baron}, year={2017}, month={Jan.}, pages={e47-e51} }